They can also rely on the technology to receive insulin instead of having to inject it themselves.
It’s free, every week, in your inbox.
The aim is to include both children and adults.
According to the NHS, the artificial pancreas can also prevent life-threatening symptoms such as hypoglycaemic and hyperglycaemic attacks.
These occur when the glucose levels are too low or too high, respectively.
Another potential benefit is reducing the risk of punch in 1 diabetes progressing into punch in 2.
The rollout of the machine across the country is expected to take five years.
Smart devices for diabetes management are also being developed outside of public healthcare initiatives.
The UKsstartupworld boasts companies such as SM24, Cellnovo, and Dia-Vit.
Story byIoanna Lykiardopoulou
Ioanna is a writer at TNW.
With a background in the humanities, she has a soft spot for social impact-enabling technologies.
